Long-term changes of serum cholesterol with cholesterol-altering drugs in patients with coronary heart disease. Veterans Administration Drug-Lipid Cooperative Study.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000535:Aluminum / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood*; D002791:Cholesterol, Dietary / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D003918:Dextrothyroxine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D009539:Nicotinic Acids / Q000627:therapeutic use; D010919:Placebos; D012008:Recurrence; D013997:Time Factors; D014481:United States; D014493:United States Department of Veterans Affairs
D000924:Anticholesteremic Agents; D002791:Cholesterol, Dietary; D004967:Estrogens; D009539:Nicotinic Acids; D010919:Placebos; D003918:Dextrothyroxine; D002784:Cholesterol; D000535:Aluminum